☰

Glenn C. Rowe, Ph.D. - Publications

Affiliations: 
2007 Yale University, New Haven, CT 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Idelevich A, Sato K, Avihai B, Nagano K, Galien A, Rowe G, Gori F, Baron R. Both NPY- and CART-expressing neurons increase energy expenditure and trabecular bone mass in response to AP1 antagonism, but have opposite effects on bone resorption. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31995643 DOI: 10.1002/Jbmr.3967  0.555
2019 De Luca M, Vecchie' D, Athmanathan B, Gopalkrishna S, Valcin JA, Swain TM, Sertie R, Wekesa K, Rowe GC, Bailey SM, Nagareddy PR. Genetic Deletion of Alters Body Composition, Metabolic Phenotypes, and the Function of Metabolic Tissues in Female Mice Fed A High-Fat Diet. Nutrients. 11. PMID 31752080 DOI: 10.3390/Nu11112810  0.328
2019 Idelevich A, Sato K, Nagano K, Rowe G, Gori F, Baron R. ΔFosB Requires Galanin, but not Leptin, to Increase Bone Mass via the Hypothalamus, but both are needed to increase Energy Expenditure. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 30998833 DOI: 10.1002/Jbmr.3741  0.585
2018 Ederer KA, Jin K, Bouslog S, Wang L, Gorman GS, Rowe GC, Abadir P, Raftery D, Moellering D, Promislow D, Jumbo-Lucioni P, De Luca M. Age- and Genotype-Specific Effects of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mitochondrial and Metabolic Parameters in . International Journal of Molecular Sciences. 19. PMID 30373167 DOI: 10.3390/Ijms19113351  0.305
2018 Bell MB, Bush Z, McGinnis GR, Rowe GC. Adult Skeletal Muscle Deletion of Mitofusin 1 and 2 Impedes Exercise Performance and Training Capacity. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 30260752 DOI: 10.1152/Japplphysiol.00719.2018  0.325
2018 Idelevich A, Sato K, Nagano K, Rowe G, Gori F, Baron R. Neuronal hypothalamic regulation of body metabolism and bone density is galanin-dependent. The Journal of Clinical Investigation. PMID 29596063 DOI: 10.1172/Jci99350  0.566
2018 McMeekin LJ, Li Y, Fox SN, Rowe GC, Crossman DK, Day JJ, Li Y, Detloff PJ, Cowell RM. Cell-specific deletion of PGC-1α from medium spiny neurons causes transcriptional alterations and age-related motor impairment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29491012 DOI: 10.1523/Jneurosci.0848-17.2018  0.353
2018 Rowe GC, Bush ZD, Bell MB, McGinnis GR. Skeletal Muscle Mitochondrial Fusion is Required for Exercise Performance and Mitochondrial Oxidative Capacity Medicine & Science in Sports & Exercise. 50: 149. DOI: 10.1249/01.Mss.0000535575.34480.99  0.3
2018 McGinnis GR, Bush ZD, Bell MB, Rowe GC. Mitochondrial Fusion Is Essential For Regulation Of Adult Skeletal Muscle Mass And Protein Synthesis Medicine & Science in Sports & Exercise. 50: 148. DOI: 10.1249/01.Mss.0000535574.26857.91  0.32
2018 Kundu A, Kho E, Shelar SB, Nam H, Brinkley G, Darshan S, Tang Y, Kirkman R, Crossman DK, Varambally S, Rowe GC, Wei S, Buckhaults P, Sudarshan S. Abstract 4483: Functional implications of PRDM16 loss in kidney cancer Cancer Research. 78: 4483-4483. DOI: 10.1158/1538-7445.Am2018-4483  0.371
2017 McGinnis GR, Tang Y, Brewer RA, Brahma MK, Stanley HL, Shanmugam G, Rajasekaran NS, Rowe GC, Frank SJ, Wende AR, Dale Abel E, Taegtmeyer H, Litovsky S, Darley-Usmar V, Zhang J, et al. Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart. Journal of Molecular and Cellular Cardiology. PMID 28736261 DOI: 10.1016/J.Yjmcc.2017.07.005  0.336
2017 McDermott-Roe C, Leleu M, Rowe GC, Palygin O, Bukowy JD, Kuo J, Rech M, Hermans-Beijnsberger S, Schaefer S, Adami E, Creemers EE, Heinig M, Schroen B, Arany Z, Petretto E, et al. Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function. Plos One. 12: e0170458. PMID 28158196 DOI: 10.1371/Journal.Pone.0170458  0.363
2017 Rowe GC, Asimaki A, Graham EL, Martin KD, Margulies KB, Das S, Saffitz JE, Arany Z. Development of Dilated Cardiomyopathy and Impaired Calcium Homeostasis with Cardiac-Specific Deletion of ESRRβ. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00446.2016. PMID 28130335 DOI: 10.1152/Ajpheart.00446.2016  0.341
2017 Sato K, Idelevich A, Nagano K, Rowe GC, Gori F, Baron R. Hypothalamic ΔFosB prevents age-related metabolic decline and functions via SNS. Aging. PMID 28121620 DOI: 10.18632/aging.101157  0.462
2016 Loyd C, Liu Y, Kim T, Holleman C, Galloway J, Bethea M, Ediger BN, Tang Y, Swain TA, Stoffers DA, Rowe GC, Young M, Steele C, Habegger KM, Hunter CS. Ldb1 Regulates Energy Homeostasis During Diet-Induced Obesity. Endocrinology. en20161791. PMID 28009534 DOI: 10.1210/En.2016-1791  0.397
2016 Hinson JT, Chopra A, Lowe A, Sheng CC, Gupta RM, Kuppusamy R, O'Sullivan J, Rowe G, Wakimoto H, Gorham J, Zhang K, Musunuru K, Gerszten RE, Wu SM, Chen CS, et al. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis. Cell Reports. 17: 3292-3304. PMID 28009297 DOI: 10.1016/J.Celrep.2016.11.066  0.33
2016 Wada S, Neinast M, Jang C, Ibrahim YH, Lee G, Babu A, Li J, Hoshino A, Rowe GC, Rhee J, Martina JA, Puertollano R, Blenis J, Morley M, Baur JA, et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes & Development. PMID 27913603 DOI: 10.1101/Gad.287953.116  0.347
2016 Ballmann C, Tang Y, Bush Z, Rowe GC. Adult Expression of PGC-1α and β in Skeletal Muscle is Not Required for Endurance Exercise-Induced Enhancement of Exercise Capacity. American Journal of Physiology. Endocrinology and Metabolism. ajpendo.00209.2016. PMID 27780821 DOI: 10.1152/Ajpendo.00209.2016  0.348
2016 Iacovelli J, Rowe GC, Khadka A, Diaz-Aguilar D, Spencer C, Arany Z, Saint-Geniez M. PGC-1α Induces Human RPE Oxidative Metabolism and Antioxidant Capacity. Investigative Ophthalmology & Visual Science. 57: 1038-51. PMID 26962700 DOI: 10.1167/Iovs.15-17758  0.337
2016 Jang C, Oh SF, Wada S, Rowe GC, Liu L, Chan MC, Rhee J, Hoshino A, Kim B, Ibrahim A, Baca LG, Kim E, Ghosh CC, Parikh SM, Jiang A, et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nature Medicine. PMID 26950361 DOI: 10.1038/Nm.4057  0.303
2014 Rowe GC, Raghuram S, Jang C, Nagy JA, Patten IS, Goyal A, Chan MC, Liu LX, Jiang A, Spokes KC, Beeler D, Dvorak H, Aird WC, Arany Z. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circulation Research. 115: 504-17. PMID 25009290 DOI: 10.1161/Circresaha.115.303829  0.327
2014 Thom R, Rowe GC, Jang C, Safdar A, Arany Z. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor γ coactivator (PGC)-1α. The Journal of Biological Chemistry. 289: 8810-7. PMID 24505137 DOI: 10.1074/Jbc.M114.554394  0.339
2014 Chan MC, Rowe GC, Raghuram S, Patten IS, Farrell C, Arany Z. Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin. Skeletal Muscle. 4: 2. PMID 24447845 DOI: 10.1186/2044-5040-4-2  0.343
2014 Rowe GC, Arany Z. Genetic models of PGC-1 and glucose metabolism and homeostasis. Reviews in Endocrine & Metabolic Disorders. 15: 21-9. PMID 24057597 DOI: 10.1007/S11154-013-9273-5  0.337
2013 Rowe GC, Patten IS, Zsengeller ZK, El-Khoury R, Okutsu M, Bampoh S, Koulisis N, Farrell C, Hirshman MF, Yan Z, Goodyear LJ, Rustin P, Arany Z. Disconnecting mitochondrial content from respiratory chain capacity in PGC-1-deficient skeletal muscle. Cell Reports. 3: 1449-56. PMID 23707060 DOI: 10.1016/J.Celrep.2013.04.023  0.32
2013 Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, Frederick DT, Hurley AD, Nellore A, Kung AL, Wargo JA, Song JS, Fisher DE, Arany Z, Widlund HR. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell. 23: 302-15. PMID 23477830 DOI: 10.1016/J.Ccr.2013.02.003  0.337
2013 Shoag J, Haq R, Zhang M, Liu L, Rowe GC, Jiang A, Koulisis N, Farrel C, Amos CI, Wei Q, Lee JE, Zhang J, Kupper TS, Qureshi AA, Cui R, et al. PGC-1 coactivators regulate MITF and the tanning response. Molecular Cell. 49: 145-57. PMID 23201126 DOI: 10.1016/J.Molcel.2012.10.027  0.333
2012 Rowe GC, El-Khoury R, Patten IS, Rustin P, Arany Z. PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. Plos One. 7: e41817. PMID 22848618 DOI: 10.1371/Journal.Pone.0041817  0.376
2012 Rowe GC, Vialou V, Sato K, Saito H, Yin M, Green TA, Lotinun S, Kveiborg M, Horne WC, Nestler EJ, Baron R. Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 1649-58. PMID 22461201 DOI: 10.1002/Jbmr.1618  0.583
2012 Finley LW, Lee J, Souza A, Desquiret-Dumas V, Bullock K, Rowe GC, Procaccio V, Clish CB, Arany Z, Haigis MC. Skeletal muscle transcriptional coactivator PGC-1α mediates mitochondrial, but not metabolic, changes during calorie restriction. Proceedings of the National Academy of Sciences of the United States of America. 109: 2931-6. PMID 22308395 DOI: 10.1073/Pnas.1115813109  0.367
2012 Addison⁎ W, Saito H, Platt I, Rowe G, Yang H, Gori F, Horne W, Baron R. Interaction between DICKKOPF-1/WNT signaling and FOSB/AP1 in the regulation of adipocyte and osteoblast commitment Bone. 50: S32. DOI: 10.1016/J.Bone.2012.02.083  0.488
2011 McDermott-Roe C, Ye J, Ahmed R, Sun XM, Serafín A, Ware J, Bottolo L, Muckett P, Cañas X, Zhang J, Rowe GC, Buchan R, Lu H, Braithwaite A, Mancini M, et al. Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature. 478: 114-8. PMID 21979051 DOI: 10.1038/Nature10490  0.308
2011 Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, et al. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. The Journal of Clinical Investigation. 121: 4003-14. PMID 21881206 DOI: 10.1172/Jci58662  0.316
2011 Rowe GC, Jang C, Patten IS, Arany Z. PGC-1β regulates angiogenesis in skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism. 301: E155-63. PMID 21364124 DOI: 10.1152/Ajpendo.00681.2010  0.359
2010 Rowe GC, Jiang A, Arany Z. PGC-1 coactivators in cardiac development and disease. Circulation Research. 107: 825-38. PMID 20884884 DOI: 10.1161/Circresaha.110.223818  0.322
2010 Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, Souza A, Cheng S, McCabe EL, Yang E, Shi X, Deo R, Roth FP, Asnani A, Rhee EP, et al. Metabolic signatures of exercise in human plasma. Science Translational Medicine. 2: 33ra37. PMID 20505214 DOI: 10.1126/Scitranslmed.3001006  0.312
2009 Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, Sawada N, Raghuram S, Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 106: 21401-6. PMID 19966219 DOI: 10.1073/Pnas.0909131106  0.318
2009 Wu M, Hesse E, Morvan F, Zhang JP, Correa D, Rowe GC, Kiviranta R, Neff L, Philbrick WM, Horne WC, Baron R. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone. 44: 528-36. PMID 19095088 DOI: 10.1016/J.Bone.2008.11.011  0.659
2009 Rowe GC, Choi CS, Neff L, Horne WC, Shulman GI, Baron R. Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology. 150: 135-43. PMID 18772235 DOI: 10.1210/En.2008-0678  0.542
2008 Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R. Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 584-95. PMID 18433296 DOI: 10.1359/Jbmr.080110  0.655
Show low-probability matches.